MedTrace Logo

Spectralis OCT Repeatability and Reproducibility Study

NCT02209077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-08-05

No results posted yet for this study

Summary

This single-center, prospective, interventional clinical study is conducted to evaluate the repeatability and reproducibility of structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT (Optical Coherence Tomography) device. Data obtained from healthy volunteers in this study are compared to those from a previous, larger healthy volunteer study that was conducted in the United States and Europe (S-2012-1), and data from glaucoma patients are compared to those from the healthy volunteers.

Conditions

Interventions

DEVICE

OCT performed to collect data from the back of the eye

comparative retinal parameters with Spectralis OCT

Sponsors & Collaborators

  • Heidelberg Engineering GmbH

    lead INDUSTRY

Principal Investigators

  • Balwantray C Chauhan, PhD · Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Canada

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02209077 on ClinicalTrials.gov